Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

Repopulated spinal cord microglia exhibit a unique transcriptome and contribute to pain resolution. Cell reports Donovan, L. J., Bridges, C. M., Nippert, A. R., Wang, M., Wu, S., Forman, T. E., Haight, E. S., Huck, N. A., Bond, S. F., Jordan, C. E., Gardner, A. M., Nair, R. V., Tawfik, V. L. 2024; 43 (2): 113683

Abstract

Microglia are implicated as primarily detrimental in pain models; however, they exist across a continuum of states that contribute to homeostasis or pathology depending on timing and context. To clarify the specific contribution of microglia to pain progression, we take advantage of a temporally controlled transgenic approach to transiently deplete microglia. Unexpectedly, we observe complete resolution of pain coinciding with microglial repopulation rather than depletion. We find that repopulated mouse spinal cord microglia are morphologically distinct from control microglia and exhibit a unique transcriptome. Repopulated microglia from males and females express overlapping networks of genes related to phagocytosis and response to stress. We intersect the identified mouse genes with a single-nuclei microglial dataset from human spinal cord to identify human-relevant genes that may ultimately promote pain resolution after injury. This work presents a comprehensive approach to gene discovery in pain and provides datasets for the development of future microglial-targeted therapeutics.

View details for DOI 10.1016/j.celrep.2024.113683

View details for PubMedID 38261512